NHS patients in England will be some of the first people in Europe to benefit from a new “truly life-transforming” treatment for cystic fibrosis, health service chief executive Sir Simon Stevens has announced today. Three in five patients with the deadly genetic condition could benefit from the ‘triple combination’ treatment produced by Vertex Pharmaceuticals. This […]

The major work programmes mapped out in this Plan are underpinned by an agreed, costed and phased NHS technology plan, building on the recommendations of the Wachter review. It will simplify patient access to care, in the most appropriate location, while supporting people in managing their own health. Specifically, during the coming two years we […]

NHS England will fund a major extension to the national HIV prevention programme led by Public Health England with the aim of supporting those most at risk and reducing the incidence of HIV infection. It has also decided to routinely commission ten new specialised treatments as part of the annual prioritisation process for specialised treatments. […]

NHS England has today (11 July) set out the results of its annual process for deciding which new treatments and services it will make available to patients. Around a hundred policies were considered over the course of the year. Many of these were considered as ‘In Year Service Developments’ – policies which are cost-saving or […]

NHS England has today (2 July) set out its planned investment decisions for certain specialised services as part of its annual commissioning round. The decision follows a three-month public consultation on the principles and processes NHS England will follow when making investment decisions. Feedback from the consultation has helped inform the way these decisions have […]